Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
Authors
Keywords
Rhabdomyosarcoma, Natural killer cells, Cytotoxicity, NK receptors, Immunotherapy
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 64, Issue 5, Pages 573-583
Publisher
Springer Nature
Online
2015-02-17
DOI
10.1007/s00262-015-1657-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
- (2013) U Thiel et al. BRITISH JOURNAL OF CANCER
- Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity
- (2013) Jens H. W. Pahl et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models
- (2012) Eva Rettinger et al. Frontiers in Oncology
- Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors
- (2011) Peter Lang et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
- (2011) Emilie P. Buddingh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands
- (2011) Beatriz Sanchez-Correa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells
- (2011) Eva Rettinger et al. CYTOTHERAPY
- NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions
- (2011) Sara Morgado et al. Journal of Innate Immunity
- NK Cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT
- (2011) Justyna Kanold et al. PEDIATRIC BLOOD & CANCER
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children
- (2010) M. M. Pfeiffer et al. HAEMATOLOGICA
- Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation
- (2010) S. Kuci et al. HAEMATOLOGICA
- A Human NK Cell Activation/Inhibition Threshold Allows Small Changes in the Target Cell Surface Phenotype To Dramatically Alter Susceptibility to NK Cells
- (2010) T. D. Holmes et al. JOURNAL OF IMMUNOLOGY
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
- (2009) Elai Davicioni et al. AMERICAN JOURNAL OF PATHOLOGY
- KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors
- (2009) Antonio Pérez-Martínez et al. PEDIATRIC BLOOD & CANCER
- Line of attack: NK cell specificity and integration of signals
- (2008) Yenan T Bryceson et al. CURRENT OPINION IN IMMUNOLOGY
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups
- (2008) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
- (2008) Dirk H.J. Verhoeven et al. MOLECULAR IMMUNOLOGY
- Cancer Immunotherapy: Will Expanding Knowledge Lead to Success in Pediatric Oncology?
- (2008) Terry J. Fry et al. PEDIATRIC CLINICS OF NORTH AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search